HIMZ ETF — Defiance Daily Target 2X Long HIMS ETF

Defiance Daily Target 2X Long HIMS ETF (HIMZ)

HIMZ is an ETF that tracks the Hims & Hers Health (HIMS). As of August 19, 2026, its distribution rate is 7.65%, its trailing-12-month yield is 7.65%, its expense ratio is 1.29%. Dividend Vision Distribution Safety Score™ is 40/100 (Caution). Fund total return is -88.9% over the past 1.4 years, 75.7 points behind HIMS at -13.2%.

At the current 7.65% distribution rate, a $10,000 investment would generate approximately $765 per year, or $63.75 per month on an equivalent basis. Actual annual payments vary.

This is a leveraged ETF that uses derivatives to pursue two times the daily price movements of Hims & Hers Health, a telehealth company. The fund carries a high expense ratio of 1.29% and does not make regular distributions, though it currently has a high distribution rate. It is designed for experienced traders seeking amplified short-term exposure to the underlying stock rather than long-term investors, as leveraged daily tracking strategies experience decay over extended periods.

HIMZ performance versus HIMS

Data as of August 19, 2026.

Fund total return is -88.9% over the past 1.4 years, 75.7 points behind HIMS at -13.2%. Its deepest 1-year drawdown was 96.2%.

HIMZ key facts

Data as of August 19, 2026.

Distribution Safety Score™

40 · Caution

Issuer

Defiance ETFs

Asset type

ETF

Asset class

Equity

Inception date

03/12/2025

Expense ratio

1.29%

Distribution rate

7.65%

Distribution frequency

Annual

Trailing yield

7.65%

Last close

$25.80

AUM

$59,968,275

Average volume

227795.0

Last dividend

$1.9740

Ex-dividend date

12/30/2025

Payment date

12/31/2025

P/E ratio

38.2146

How Dividend Vision calculates yield and returns

Distribution rate (7.65%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (7.65%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Fund total return uses split-adjusted close with distributions reinvested from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is what the fund did, not your personal gain/loss. Figures below use Dividend Vision data as of August 19, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of August 19, 2026.

Primary sources: Defiance ETFs; Index: Hims & Hers Health (HIMS); prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HIMZ risks and drawbacks

Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed HIMS over the available window. The deepest 1-year drawdown on record here is 96.2%.

Who may consider HIMZ — and who may not

It is a weaker fit for investors who need monthly cash flow (HIMZ pays annual); investors whose main goal is matching HIMS total return. This is educational context, not a recommendation to buy or sell.

Frequently asked questions

More funds from Defiance ETFs.